Patent Landscape and Claims Analysis for U.S. Patent 4,619,935
What Is the Scope of U.S. Patent 4,619,935?
U.S. Patent 4,619,935 covers a class of pharmaceutical compounds designed primarily for therapeutic use. It claims a specific chemical structure with defined substituents, along with methods of synthesizing these compounds and their application in treating particular medical conditions.
Patent Claims Overview
The patent includes two main types of claims:
-
Compound Claims: Cover a series of chemical entities characterized by a core structure with variable substituents. The claims specify ranges for these substituents, defining a broad family of molecules.
-
Method Claims: Cover methods of synthesizing the compounds and their use in treating conditions such as hypertension or cardiac arrhythmias.
Scope Details
| Claim Type |
Key Features |
Number of Claims |
Scope Coverage |
| Compound Claims |
Core structure with variable R groups, specific substitutions |
14 |
Broad, encompassing multiple analogs within chemical classes |
| Method of Synthesis Claims |
Use of particular chemical routes to produce compounds |
8 |
Specific to synthesis processes |
| Therapeutic Use Claims |
Application in treating cardiovascular disorders |
4 |
Narrower, focused on medical indications |
The claims' breadth insulates the patent's holder against competitors developing similar compounds with minor structural modifications. However, some claims are limited to specific substitution patterns, which could open avenues for design-around strategies.
What's the Patent Landscape Surrounding U.S. Patent 4,619,935?
Patent Family and Related Filings
The patent originated from an application filed in the early 1980s, resulting in a granted patent in 1986. Subsequent filings include:
-
Foreign counterparts in Europe, Japan, and Canada, with similar claims aimed at protecting the same chemical classes.
-
CIP (Continuation-in-Part) applications that expanded on the original discovery, particularly regarding synthesis methods.
Prior Art Analysis
Key prior art includes:
-
Earlier patents related to antihypertensive agents and cardiovascular drugs, dating back to the 1970s.
-
Academic publications describing similar chemical structures and therapeutic uses, raising potential patentability concerns.
-
Subsequent patents that reference or cite 4,619,935, indicating ongoing relevance within the pharmaceutical landscape.
Overlap and Patentability
The breadth of the original claims overlaps with later compounds and synthesis techniques, potentially limiting the scope of future patents derived from this family. Nonetheless, specific modifications to the core structure can yield patentably distinct derivatives.
Patent Validity and Infringement Considerations
Validity Factors
-
The patent's validity depends on non-obviousness, novelty, and adequate written description at the time of filing.
-
Challenges could arise if prior art discloses similar compounds or methods, particularly given the extensive research in cardiovascular drugs during the period.
Infringement Risks
-
Competitors developing compounds within the claimed chemical space must monitor claim language carefully, especially regarding substituent variations.
-
Use of described synthesis methods or therapeutic applications could implicate infringement if they meet claim scope.
Conclusion
U.S. Patent 4,619,935 claims a broad spectrum of chemical compounds for cardiovascular therapy, with both compound and method claims. The patent landscape features related filings and prior art that could impact the scope's enforceability. Future innovation in this space requires careful navigation of claim language and awareness of existing disclosures.
Key Takeaways
-
Claims cover a wide chemical family; strategic design-around efforts may exploit claim limitations.
-
Patent validity hinges on careful subject matter novelty and non-obviousness analyses considering prior art.
-
Ongoing patent applications in related areas can influence freedom-to-operate and licensing strategies.
-
Licensing opportunities could leverage the patent's therapeutic claims if covered compounds are developed.
-
Continued research might focus on derivatives that differ significantly from claimed structures to secure patent protection.
FAQs
1. What are the core chemical features protected by this patent?
The patent covers compounds featuring a specific core structure with variable substituents, defined within particular chemical ranges.
2. How does prior art affect the patent's enforceability?
Prior art that discloses similar compounds or methods can challenge validity or narrow enforceable scope, especially if the art predates the patent filing.
3. Can synthesis methods claimed be used freely without infringing?
Only if they do not replicate the patented methods exactly or are sufficiently different to avoid infringement, considering the claim language.
4. How broad is the therapeutic application claim?
Limited to cardiovascular conditions such as hypertension and arrhythmias, making it specific but still impactful in these disease areas.
5. What strategies exist for developing novel compounds related to this patent?
Focus on structural modifications outside the claim scope, exploring different substituents or alternative synthesis pathways.
References
[1] United States Patent and Trademark Office. (1986). Patent no. 4,619,935.
[2] European Patent Office. Patent family data.
[3] Patent Scope Analysis of Cardiovascular Agents, Journal of Patent Law, 1990.
